Chronic kidney disease progression in patients with resistant hypertension subject to 2 therapeutic strategies: Intensification with loop diuretics vs aldosterone antagonists U. Verdalles, M. Goicoechea, S. García de Vinuesa, E. Torres, A. Hernández, E. Verde, A. Pérez de José, J. Luño

Obesity, chronic kidney disease progression and the role of the adipokine C1q/TNF related protein-3 Diego Barbieri, Marian Goicoechea, Eduardo Verde, Ana García-Prieto, Úrsula Verdalles, Ana Pérez de José, Andrés Delgado, Maria Dolores Sánchez-Niño, Alberto Ortiz

Risk factors for progression in patients with KDOQI stage 3 Chronic Kidney Disease (PROGRESER study) Alberto Martínez-Castelao, José Luis Górriz Teruel, Luis D’Marco, Enrique Garrigós, Gema Fernández-Fresnedo, Eugenia Espinel Garuz, Secundino Cigarrán Guldris, Jesús Arteaga Coloma, Nicolas Roberto Robles Pérez-Monteoliva, José Rafael Esteban de la Rosa, Luis Javier Nieto Iglesias, Alberto Ortiz Arduán, Juan Francisco Navarro-González